A detailed history of Probity Advisors, Inc. transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 23,045 shares of HCAT stock, worth $179,059. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,045
Previous 20,346 13.27%
Holding current value
$179,059
Previous $130,000 43.85%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$5.48 - $8.83 $14,790 - $23,832
2,699 Added 13.27%
23,045 $187,000
Q2 2024

Aug 14, 2024

BUY
$5.53 - $7.28 $34,861 - $45,893
6,304 Added 44.89%
20,346 $130,000
Q1 2024

May 02, 2024

BUY
$7.44 - $11.21 $104,472 - $157,410
14,042 New
14,042 $105,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $425M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Probity Advisors, Inc. Portfolio

Follow Probity Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.